• Lipo3K Transfection Reagent: Practical Cell Workflows

  2026-08-11

  Lipo3K Transfection Reagent combines high nucleic acid delivery with a low-toxicity workflow for adherent, suspension, and difficult-to-transfect cells. This guide connects practical DNA, siRNA, mRNA, and co-transfection strategies with a pH-responsive antisense oligonucleotide study, helping researchers choose controls, timing, and troubleshooting steps more confidently.

• AL-8810: A Causal Map of FP Receptor Signaling

  2026-08-10

  AL-8810 is a prostaglandin F2α antagonist for resolving FP receptor-dependent signaling rather than merely measuring pathway association. This guide translates pharmacology, endometrial findings, and assay-design principles into a practical framework for causal research.

• AAL-993 and the Translational Logic of Angiogenesis

  2026-08-09

  A mechanistic and strategic guide to using AAL-993 as a VEGF receptor inhibitor in tumor angiogenesis research, with practical considerations for melanoma models, vascular readouts, and carefully bounded exploration of glioma biology.

• SB-505124 Hydrochloride for TGF-β Research

  2026-08-08

  SB-505124 hydrochloride is a reversible, ATP-competitive inhibitor of ALK4, ALK5, and ALK7 used to dissect TGF-β/activin signaling. Supplier-reported benchmarks support studies of Smad2/3 phosphorylation, fibroblast activation, fibrosis, and glaucoma filtration surgery models.

• Ibrexafungerp Against Fluconazole-Resistant Candida auris

  2026-08-07

  Wiederhold and colleagues evaluated ibrexafungerp against 54 Candida auris isolates and in a neutropenic mouse model of invasive candidiasis with therapy delayed for 24 hours. The findings support oral glucan synthase inhibition as a promising strategy against fluconazole-resistant C. auris, while also showing why comparator choice, infection model, and treatment timing matter when interpreting antifungal efficacy.

• Pexidartinib (PLX3397): Precision CSF1R Modulation for Tumor

  2026-08-07

  Explore how Pexidartinib (PLX3397) enables advanced CSF1R-mediated signaling inhibition and precise tumor microenvironment macrophage modulation. This article offers novel insights for oncology research, bridging molecular action with translational assay design.

• BAPTA-AM: Cell-Permeable Calcium Chelator for Precision Assa

  2026-08-06

  BAPTA-AM empowers researchers with fast, selective intracellular calcium chelation, enabling robust control of calcium signaling and cell death pathways in complex models. Its cell-permeable design and dual ion channel modulation unlock advanced workflows in apoptosis, neuroprotection, and real-time fluorescence assays.

• Cell Surface GlycoRNA–RBP Clusters Enable Peptide Entry: New

  2026-08-06

  The referenced study uncovers that RNA binding proteins (RBPs), together with glycoRNAs, form structured nanodomains on the cell surface, facilitating the entry of cell-penetrating peptides like TAT. This discovery challenges traditional models of membrane composition and suggests new targets for probing cell-surface interactomes.

• C8-HSL Promotes Lung Cancer Cell Aggressiveness via PI3K/AKT

  2026-08-05

  The referenced study demonstrates that the bacterial quorum-sensing molecule N-octanoyl-L-Homoserine lactone (C8-HSL) directly enhances the proliferation, migration, and invasion of lung cancer cells by activating the PI3K/AKT/ERK pathway. These findings highlight a mechanistic link between microbial signaling and tumor progression, offering new avenues for infection biology and microbial pathogenicity research.

• Targeted CRISPRi Delivery to Adipocytes Ameliorates Metaboli

  2026-08-05

  This study demonstrates a nonviral, adipocyte-targeted CRISPR interference (CRISPRi) system that silences Fabp4, resulting in reduced obesity, inflammation, hepatic steatosis, and insulin resistance in mice. The work establishes a precise, tissue-specific genetic approach for metabolic disease intervention, highlighting its translational potential for safer, more effective therapies.

• Chlorpromazine HCl (SKU B1480): Reliable Dopamine Antagonist

  2026-08-04

  This scenario-driven article addresses common laboratory pain points in cell viability and neuropharmacology studies, demonstrating how Chlorpromazine HCl (SKU B1480) delivers reproducible, literature-backed solutions for dopamine receptor inhibition and related workflows. By integrating real-world Q&A, protocol insights, and product comparison, we help researchers select and optimize Chlorpromazine HCl for advanced biomedical assays.

• Chloroquine Diphosphate: Precision Autophagy Modulation in C

  2026-08-04

  Explore how Chloroquine diphosphate enables precise autophagy modulation and cell cycle control for advanced cancer research, with expert insight into assay design and sensitivity. This article offers a distinct, protocol-driven analysis linking mechanism to workflow.

• Crizotinib hydrochloride: Reliable ALK Kinase Inhibition in

  2026-08-03

  This article presents evidence-backed strategies for integrating Crizotinib hydrochloride (SKU B3608) into advanced cancer biology workflows. Through real laboratory scenarios, it demonstrates how this ATP-competitive ALK kinase inhibitor offers reproducible inhibition of oncogenic signaling, supports robust data interpretation, and enhances compatibility with assembloid models. Benchmarking against common alternatives, the article positions SKU B3608 as a dependable choice for researchers demanding high purity and consistent results.

• Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP): Mechanisms & Be

  2026-08-03

  Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) enables robust, low-immunogenicity bioluminescent reporting for gene expression and cell viability assays. Incorporating ARCA capping and nucleotide modifications, this reagent delivers enhanced stability and translation efficiency. Benchmark data confirm its reliability as a gold-standard reporter in high-sensitivity workflows.

• Lipo3K Transfection Reagent: High-Efficiency Gene Modulation

  2026-08-02

  Lipo3K Transfection Reagent delivers superior nucleic acid transfection, even in challenging cell lines, enabling robust gene expression and RNA interference studies. Its unique formulation with Lipo3K-A enhancer boosts nuclear DNA delivery while minimizing cytotoxicity, setting a new standard for DNA and siRNA co-transfection workflows.

15472 records 1/1032 page Next 12345 下5页 Last page